The majority of B-ALL cases with post-chemotherapy lower TNF-a levels had complete remission (90.3%), while the majority of cases with post-chemotherapy higher TNF-a levels had incomplete remission (90.9%). This evidence concerns the gene TNF and acute lymphoblastic leukemia.